Bernjak, Alan
Chow, Elaine
Robinson, Emma J.
Freeman, Jenny
Marques, Jefferson L. B.
Macdonald, Ian A.
Sheridan, Paul J.
Heller, Simon R. http://orcid.org/0000-0002-2425-9565
Funding for this research was provided by:
National Institute for Health Research
Diabetes UK (RB113202)
Sheffield Hospitals Charity (R/115143)
Article History
Received: 4 July 2019
Accepted: 13 January 2020
First Online: 7 February 2020
Authors’ relationships and activities
: SRH has served as a consultant or speaker for Lilly, Novo Nordisk, Takeda, Boehringer Ingelheim, Mannkind, Sanofi Aventis, Zealand Pharma and UN-EEG. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.